Method to treat rheumatoid arthritis

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/19 (2006.01) A61K 38/13 (2006.01) A61K 39/00 (2006.01) A61K 39/39 (2006.01) A61K 39/395 (2006.01) C07K 14/74 (2006.01) C07K 16/28 (2006.01) C07K 19/00 (2006.01)

Patent

CA 2056450

2056450 9014835 PCTABS00002 Subjects may be immunized against rheumatoid arthritis by administering the peptide Q(K/R)RAA in immunogenic form in a protocol leading to preferential expansion of suppressor and/or cytotoxic T-cells rather than helper T-cells. This preferential expansion can be effected by administration of interleukin-6 and/or cyclosporin A. Alternatively, the Q(K/R)RAA peptide coupled to the invariant region of a Class I histocompatibility sequence may be administered. Also disclosed are pharmaceutical compositions useful in the vaccination protocols.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method to treat rheumatoid arthritis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method to treat rheumatoid arthritis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method to treat rheumatoid arthritis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1641166

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.